BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 3.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,130,000 | -31.3% | 82,959 | +0.4% | 0.00% | -50.0% |
Q3 2016 | $1,644,000 | +53.2% | 82,628 | -0.2% | 0.00% | +100.0% |
Q2 2016 | $1,073,000 | +284.6% | 82,773 | +177.7% | 0.00% | – |
Q1 2016 | $279,000 | -53.0% | 29,811 | +1.8% | 0.00% | -100.0% |
Q4 2015 | $594,000 | +42.4% | 29,287 | +1.9% | 0.00% | 0.0% |
Q3 2015 | $417,000 | -34.9% | 28,730 | -4.7% | 0.00% | 0.0% |
Q2 2015 | $641,000 | +11.1% | 30,149 | +21.1% | 0.00% | 0.0% |
Q1 2015 | $577,000 | – | 24,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 1,051,441 | $1,356,000 | 0.23% |
X-Square Capital, LLC | 199,791 | $258,000 | 0.15% |
Nikko Asset Management Americas, Inc. | 2,300,682 | $2,968,000 | 0.05% |
SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $516,000 | 0.04% |
Baker Brothers Advisors | 2,677,818 | $3,454,000 | 0.02% |
SHUFRO ROSE & CO LLC | 129,417 | $167,000 | 0.02% |
ARK Investment Management | 417,433 | $538,000 | 0.01% |
ALGERT GLOBAL LLC | 36,806 | $47,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 352,465 | $455,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 66,472 | $86,000 | 0.01% |